Company
Design Therapeutics Inc.
Pioneering the field of Small Molecule Genomic Medicine
Also known as Design Therapeutics
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- Design Therapeutics, Inc.
- designtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are a biopharmaceutical company advancing novel, small molecule therapeutic candidates designed to bring functional cures to serious genetic diseases with long-standing unmet need.
Funding snapshot
- Total raised
- $171MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $125M2021-01-25
Funding rounds
- Round, 2021
- $125M2021-01-25, SEC form D sold, 26 investors
- Round, 2020
- $45.5M2020-02-21, SEC form D sold, 6 investors
Products
- Web
- GeneTAC
Loading relationship preview